Decrease the risk of colorectal cancer in postmenopausal women; have a protective effect in the development and progression of intestinal tumors; reduce morbidity and mortality associated with colorectal cancer; ERβ can serve as a favorable prognostic indicator in the management of colorectal cancer. This evidence concerns the gene ESR2 and intestinal neoplasm.